TransMedics Group, Inc. (BIT:1TMDX)
113.70
-4.35 (-3.68%)
At close: Dec 5, 2025
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| United States Lung Revenue | 14.60M | 15.76M |
Log In |
Log In |
Log In | Upgrade
|
| United States Heart Revenue | 110.58M | 96.66M |
Log In |
Log In |
Log In | Upgrade
|
| United States Liver Revenue | 421.29M | 309.46M |
Log In |
Log In |
Log In | Upgrade
|
| United States OCS Transplant Revenue | 546.46M | 421.88M |
Log In |
Log In |
Log In | Upgrade
|
| All Other Countries Lung Revenue | 1.52M | 1.93M |
Log In |
Log In |
Log In | Upgrade
|
| All Other Countries Heart Revenue | 13.63M | 13.20M |
Log In |
Log In |
Log In | Upgrade
|
| All Other Countries Liver Revenue | 600.00K | 158.00K |
Log In |
Log In |
Log In | Upgrade
|
| All Other Countries OCS Transplant Revenue | 15.75M | 15.28M |
Log In |
Log In |
Log In | Upgrade
|
| Total OCS Transplant Revenue | 562.95M | 437.16M |
Log In |
Log In |
Log In | Upgrade
|
| Other Service Revenue | - | 4.38M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -1.12B | -874.32M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 566.35M | 441.54M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Net Product Revenue | 346.96M | 273.87M |
Log In |
Log In |
Log In | Upgrade
|
| Service Revenue | 219.40M | 167.67M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 566.35M | 441.54M |
Log In |
Log In |
Log In | Upgrade
|